A Novartis multicenter, double-blind, randomized withdrawal extension study of subcutaneous XXXXXXXXXX to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenitis suppurativa.
To participate in your local study, please contact (949) 844-0442 or fill out the form below.
Protocol # CAIN457M2301E1
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.